4/A: Eyenovia Director Rachel Jacobson Corrects Beneficial Ownership Report After Betaliq Merger

Rachel Jacobson, a director at Eyenovia, Inc., files an amended Form 4/A to correct a clerical error in the original filing regarding the amount of securities beneficially owned, following a reverse stock split and ahead of a proposed business combination with Betaliq, Inc.

Summary

• Rachel Jacobson, a director at Eyenovia, Inc., filed an amended Form 4/A on April 29, 2025, to correct a clerical error in the original Form 4 filed on April 23, 2025.
• The original filing incorrectly reported the amount of securities beneficially owned by Jacobson.
• The corrected filing shows that Jacobson beneficially owns 4,301 shares of common stock.
• Jacobson also holds restricted stock units that will fully vest upon the closing of Eyenovia's proposed business combination with Betaliq, Inc., subject to continued service.
• On January 31, 2025, Eyenovia effected a 1-for-80 reverse stock split, and Jacobson's ownership has been adjusted to reflect this split.
• The transaction date for the acquisition of 3,000 shares of common stock is April 21, 2025, at a price of $0.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing correcting a clerical error. It doesn't contain any significantly positive or negative news, but the correction itself is a positive sign of diligence.

Future Outlook

The vesting of restricted stock units is contingent upon the closing of the proposed business combination with Betaliq, Inc., and the reporting person's continued service to the issuer.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The correction of the filing ensures accurate information for shareholders regarding insider ownership.
• The vesting of restricted stock units impacts the director's holdings and alignment with the company's success.

Next Steps

• Closing of the proposed business combination with Betaliq, Inc., which will trigger the vesting of restricted stock units.

Key Dates

Keywords

Form 4/A, Eyenovia, Rachel Jacobson, Beneficial Ownership, Betaliq, Reverse Stock Split, Director, Securities